Parallax Volatility Advisers
KALA icon

Parallax Volatility Advisers’s KALA BIO KALA Stock Holding History

Parallax Volatility Advisers’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-4
Closed -$54K – 3460
2018
Q4 		$54K Buy
+4
New +$69.3K ﹤0.01% 2092
2018
Q1 		– Hold
0
– -$23K – 3317
2017
Q4 		– Hold
0
– – – 3619

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Parallax Volatility Advisers's KALA Position: Q1 2019 in Review

Parallax Volatility Advisers sold out of KALA BIO (KALA) in Q1 2019, closing a stake of 4 shares — an estimated $54K sold.

Parallax Volatility Advisers first reported a position in KALA in Q4 2018 and held it in 1 quarter. The position peaked at $54K in Q4 2018. 68 funds tracked by Wall St. Rank hold KALA as of Q1 2019.

  • Parallax Volatility Advisers reported no remaining KALA BIO position as of Q1 2019 after selling out during the quarter.
  • Parallax Volatility Advisers sold 4 KALA BIO shares in Q1 2019, an estimated $54K.
  • Parallax Volatility Advisers first reported a position in KALA BIO in Q4 2018 and held it in 1 quarter.
  • Parallax Volatility Advisers's KALA BIO position peaked at $54K in Q4 2018.
  • 68 funds tracked by Wall St. Rank held KALA BIO as of Q1 2019.

Based on Parallax Volatility Advisers's 13F filing for Q1 2019, filed 15 May 2019.